Berkshire Money Management, Inc. Pfizer Inc Transaction History

Berkshire Money Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $26,339 - $34,211	-1,008 Reduced 4.53%	21,255 $611,000
Q3 2023 Oct 17, 2023	BUY	$32.09 - $37.51 $24,067 - $28,132	750 Added 3.49%	22,263 $738,000
Q2 2023 Aug 07, 2023	BUY	$36.12 - $41.79 $13,508 - $15,629	374 Added 1.77%	21,513 $789,000
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $451,275 - $589,090	10,809 Added 104.64%	21,139 $1.08 Million
Q3 2022 Oct 21, 2022	BUY	$43.76 - $53.42 $3,063 - $3,739	70 Added 0.68%	10,330 $452,000
Q2 2022 Jul 14, 2022	SELL	$46.53 - $55.17 $2,884 - $3,420	-62 Reduced 0.6%	10,260 $538,000
Q1 2022 Apr 19, 2022	BUY	$45.75 - $56.69 $472,231 - $585,154	10,322 New	10,322 $534,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Berkshire Money Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Berkshire Money Management, Inc. with notifications on news.